{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T14:19:38Z","timestamp":1778077178343,"version":"3.51.4"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"13","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,27]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Rheumatoid arthritis (RA) is a chronic autoimmune disease known for its systemic inflammatory effects and associated comorbidities. Chronic obstructive pulmonary disease (COPD) has been increasingly recognized as a significant comorbidity in RA patients. This meta-analysis aims to quantify the prevalence and relative risk of COPD in patients with RA compared to the general population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      A systematic search of PubMed, Embase, and Google Scholar was conducted until April 30th, 2024. Studies were selected based on predefined inclusion criteria, focusing on those reporting data on COPD in RA patients. Random-effects models were used to estimate pooled prevalence rate and risk ratios, along with 95% confidence intervals (CIs), to report the overall effect size. Statistical significance was set at\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05. Statistical analyses were conducted using Review Manager and MedCalc software, with results pooled using the Mantel-Haenszel random-effects model. Heterogeneity was assessed using I\n                      <jats:sup>2<\/jats:sup>\n                      statistics, and publication bias was evaluated using funnel plots, Egger regression, and Begg rank correlation tests.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Twenty-four studies with a combined population of 1,710,600 individuals were included. The pooled prevalence of COPD in RA patients was 7.06% (95% CI 4.56\u201310.13). Subgroup analysis showed a prevalence of 6.36% in Asia and 7.1% in the studies from the rest of the world. RA patients had a significantly higher risk of developing COPD compared to the general population, with an risk ratios of 1.58 (95% CI 1.37\u20131.82,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.0001). The relative risk in Asian populations was 1.61 (95% CI, 1.19\u20132.18,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.0001) compared to 1.56 (95% CI, 1.24\u20131.97,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.0001) in studies from the rest of the world. According to Newcastle\u2013Ottawa Scale, most studies were of high or moderate quality. According to Egger regression and Begg rank correlation tests, all analyses were free of publication bias.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This meta-analysis offers strong evidence that individuals with RA are at a significantly higher risk of developing COPD. These findings emphasize the need for regular screening for COPD in RA patients and the implementation of proactive management strategies to reduce this risk. Further research is required to fully understand this relationship.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048112","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T17:01:12Z","timestamp":1774630872000},"page":"e48112","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and risk of chronic obstructive pulmonary disease in rheumatoid arthritis: Systematic review and meta-analysis"],"prefix":"10.1097","volume":"105","author":[{"given":"Sawai","family":"Singh Rathore","sequence":"first","affiliation":[{"name":"Dr. Sampurnanand Medical College, Jodhpur, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.T. Mohammed","family":"Rizwan","sequence":"additional","affiliation":[{"name":"Jubilee Mission Medical College and Research Institute, Thrissur, Kerala, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ogechukwu","family":"Samuel Obi","sequence":"additional","affiliation":[{"name":"New York Institute of Technology College of Osteopathic Medicine, Glen Head, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shravya","family":"Krishna Kokkula","sequence":"additional","affiliation":[{"name":"Dr.Vasantrao Pawar Medical College, Hospital and Research Center, Nashik, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn","family":"Adams","sequence":"additional","affiliation":[{"name":"Washington University of Health and Science, San Pedro, Belize"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gredeline","family":"Nhomme Jeudy","sequence":"additional","affiliation":[{"name":"Washington University of Health and Science, San Pedro, Belize"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Cicani","sequence":"additional","affiliation":[{"name":"International University of Health Sciences, Basseterre, Saint Kitts and Nevis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ifeanyi","family":"Ononuju","sequence":"additional","affiliation":[{"name":"University of Science, Arts and Technology, Montserrat"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8128-4466","authenticated-orcid":false,"given":"Tahera","family":"Ahmadi","sequence":"additional","affiliation":[{"name":"Medical Faculty, Herat University, Herat, Afghanistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bijay Mukesh","family":"Jeswani","sequence":"additional","affiliation":[{"name":"GCS Medical College, Hospital and Research Centre, Ahmedabad, India."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260506","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41392-023-01331-9","article-title":"Signaling pathways in rheumatoid arthritis: implications for targeted therapy.","volume":"8","author":"Ding","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"R2-20260506","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.chest.2024.03.005","article-title":"Rheumatoid arthritis and COPD.","volume":"165","author":"Rossides","year":"2024","journal-title":"Chest"},{"key":"R3-20260506","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/1744666X.2019.1698293","article-title":"Obstructive lung diseases and risk of rheumatoid arthritis.","volume":"16","author":"Friedlander","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"key":"R4-20260506","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"R5-20260506","doi-asserted-by":"crossref","first-page":"11678","DOI":"10.1038\/s41598-023-37452-y","article-title":"Epidemiology and clinical characteristics of interstitial lung disease in patients with rheumatoid arthritis from the JointMan database.","volume":"13","author":"Zhuo","year":"2023","journal-title":"Sci Rep"},{"key":"R6-20260506","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1063012","article-title":"Airflow obstruction as a marker of adverse prognosis in rheumatoid arthritis.","volume":"10","author":"Guiot","year":"2023","journal-title":"Front Med"},{"key":"R7-20260506","doi-asserted-by":"crossref","first-page":"26335565221148616","DOI":"10.1177\/26335565221148616","article-title":"Classification of long-term condition patterns in rheumatoid arthritis and associations with adverse health events: a UK Biobank cohort study.","volume":"13","author":"McLoone","year":"2023","journal-title":"J Multimorb Comorb"},{"key":"R8-20260506","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5578\/tt.20219801","article-title":"Evaluation of pulmonary involvement in systemic rheumatic diseases with high resolution computed tomography and pulmonary function test: a single-center experience.","volume":"69","author":"Pazarli","year":"2021","journal-title":"Tuberk Toraks"},{"key":"R9-20260506","first-page":"e19432","article-title":"Prevalence of common comorbidities in rheumatoid arthritis in rural new york compared with national data.","volume":"13","author":"Fuller","year":"2021","journal-title":"Cureus"},{"key":"R10-20260506","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/1756-185X.14129","article-title":"Prevalence of chronic obstructive pulmonary disease in patients with rheumatoid arthritis: a cross\u2010sectional study.","volume":"24","author":"Jung","year":"2021","journal-title":"Int J Rheum Dis"},{"key":"R11-20260506","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keaa321","article-title":"Comparable or higher prevalence of comorbidities in antiphospholipid syndrome vs rheumatoid arthritis: a multicenter, case-control study.","volume":"60","author":"Panopoulos","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"R12-20260506","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2147\/COPD.S233441","article-title":"Association of Chinese herbal medicines use with development of chronic obstructive pulmonary disease among patients with rheumatoid arthritis: a population-based cohort study.","volume":"15","author":"Lin","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"R13-20260506","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1007\/s10067-018-4314-9","article-title":"Chronic lung disease in U.S. Veterans with rheumatoid arthritis and the impact on survival.","volume":"37","author":"England","year":"2018","journal-title":"Clin Rheumatol"},{"key":"R14-20260506","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.rmed.2018.06.010","article-title":"Increased mortality among patients with rheumatoid arthritis and COPD: a population-based study.","volume":"140","author":"Hyldgaard","year":"2018","journal-title":"Respir Med"},{"key":"R15-20260506","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/20009666.2018.1485460","article-title":"Prevalence of chronic obstructive pulmonary disease (COPD) among rheumatoid arthritis: results from national inpatient database.","volume":"8","author":"Dhital","year":"2018","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"R16-20260506","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.semarthrit.2017.09.005","article-title":"Rheumatoid arthritis and risk of chronic obstructive pulmonary disease or asthma among women: a marginal structural model analysis in the Nurses\u2019 Health Study.","volume":"47","author":"Sparks","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"R17-20260506","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/acr.23410","article-title":"Risk of incident chronic obstructive pulmonary disease in rheumatoid arthritis: a population\u2010based cohort study.","volume":"71","author":"Mcguire","year":"2018","journal-title":"Arthritis Care Res"},{"key":"R18-20260506","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00296-016-3628-7","article-title":"Gender-associated comorbidities in rheumatoid arthritis and their impact on outcome: data from GENIRA.","volume":"37","author":"Aurrecoechea","year":"2017","journal-title":"Rheumatol Int"},{"key":"R19-20260506","doi-asserted-by":"crossref","first-page":"e0153217","DOI":"10.1371\/journal.pone.0153217","article-title":"Different risk of tuberculosis and efficacy of isoniazid prophylaxis in rheumatoid arthritis patients with biologic therapy: a nationwide retrospective cohort study in Taiwan.","volume":"11","author":"Liao","year":"2016","journal-title":"PLoS One"},{"key":"R20-20260506","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/qjmed\/hcu027","article-title":"Increased risk of chronic obstructive pulmonary disease in patients with rheumatoid arthritis: a population-based cohort study.","volume":"107","author":"Shen","year":"2014","journal-title":"QJM"},{"key":"R21-20260506","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/acr.21986","article-title":"Incidence and mortality of obstructive lung disease in rheumatoid arthritis: a population-based study.","volume":"65","author":"Nannini","year":"2013","journal-title":"Arthritis Care Res"},{"key":"R22-20260506","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1471-2296-14-199","article-title":"Increased risk for chronic comorbid disorders in patients with inflammatory arthritis: a population based study.","volume":"14","author":"Ursum","year":"2013","journal-title":"BMC Fam Pract"},{"key":"R23-20260506","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/annrheumdis-2013-204223","article-title":"Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA).","volume":"73","author":"Dougados","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R24-20260506","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s12026-013-8395-x","article-title":"Autoimmune smoke and fire\u2014coexisting rheumatoid arthritis and chronic obstructive pulmonary disease: a cross-sectional analysis.","volume":"56","author":"Bieber","year":"2013","journal-title":"Immunol Res"},{"key":"R25-20260506","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.semarthrit.2010.08.005","article-title":"Cancer in patients with rheumatic diseases exposed to TNF antagonists.","volume":"41","author":"Carmona","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"R26-20260506","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1002\/art.27660","article-title":"No evidence of association between anti-tumor necrosis factor treatment and mortality in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.","volume":"62","author":"Lunt","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R27-20260506","doi-asserted-by":"crossref","DOI":"10.55563\/clinexprheumatol\/i9au1r","article-title":"Association between chronic obstructive pulmonary disease, smoking, and interstitial lung disease onset in rheumatoid arthritis.","author":"Zheng","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"R28-20260506","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keaa836","article-title":"Prevalence, incidence and cause-specific mortality of rheumatoid arthritis\u2013associated interstitial lung disease among older rheumatoid arthritis patients.","volume":"60","author":"Sparks","year":"2021","journal-title":"Rheumatology"},{"key":"R29-20260506","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-019-1123-x","article-title":"Chronic obstructive pulmonary disease in rheumatoid arthritis: a systematic review and meta-analysis.","volume":"20","author":"Ma","year":"2019","journal-title":"Respir Res"},{"key":"R30-20260506","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/09059180.00008014","article-title":"Rheumatoid arthritis-associated lung disease.","volume":"24","author":"Shaw","year":"2015","journal-title":"Eur Respir Rev"},{"key":"R31-20260506","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/resp.13436","article-title":"Genetic risk factors for the development of pulmonary disease identified by genome-wide association.","volume":"24","author":"Hall","year":"2018","journal-title":"Respirology"},{"key":"R33-20260506","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/ijerph15051033","article-title":"Tobacco smoke induces and alters immune responses in the lung triggering inflammation, allergy, asthma and other lung diseases: a mechanistic review.","volume":"15","author":"Strzelak","year":"2018","journal-title":"Int J Environ Res Public Health"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048112","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T14:00:59Z","timestamp":1778076059000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":32,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048112","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"2024-09-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}